Cargando…

Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections

Despite efforts made to develop efficient preventive strategies, infections with influenza A viruses (IAV) continue to cause serious clinical and economic problems. Current licensed human vaccines are mainly inactivated whole virus particles or split-virion administered via the parenteral route. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calzas, Cynthia, Chevalier, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650573/ https://www.ncbi.nlm.nih.gov/pubmed/31379823 http://dx.doi.org/10.3389/fimmu.2019.01605

Ejemplares similares

Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens
por: Calzas, Cynthia, et al.
Publicado: (2021)

Editorial: Innovative Therapeutic and Vaccine Approaches Against Respiratory Pathogens
por: Calzas, Cynthia, et al.
Publicado: (2019)

Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection
por: Corthésy, Blaise, et al.
Publicado: (2018)

A DNA Vaccine Formulated with Chemical Adjuvant Provides Partial Protection against Bovine Herpes Virus Infection in Cattle
por: Quattrocchi, Valeria, et al.
Publicado: (2017)

Induction of Mucosal IgA–Mediated Protective Immunity Against Nontypeable Haemophilus influenzae Infection by a Cationic Nanogel–Based P6 Nasal Vaccine
por: Nakahashi-Ouchida, Rika, et al.
Publicado: (2022)

Mucosal Vaccination Against Periodontal Disease: Current Status and Opportunities
por: Vaernewyck, Victor, et al.
Publicado: (2021)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
por: Dong, Wei, et al.
Publicado: (2018)

Challenges for the Newborn Following Influenza Virus Infection and Prospects for an Effective Vaccine
por: Alexander-Miller, Martha A.
Publicado: (2020)

A Review of DNA Vaccines Against Influenza
por: Lee, Leo Yi Yang, et al.
Publicado: (2018)

Mucosal Vaccination Primes NK Cell-Dependent Development of CD8(+) T Cells Against Pulmonary Brucella Infection
por: Bhagyaraj, Ella, et al.
Publicado: (2021)

Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus
por: Bodas-Pinedo, Andrés, et al.
Publicado: (2023)

Editorial: Influenza Virus Vaccines and Immunotherapies
por: Kumar, Arun, et al.
Publicado: (2015)

H1N1 Influenza Virus-Infected Nasal Mucosal Epithelial Progenitor Cells Promote Dendritic Cell Recruitment and Maturation
por: Zhu, Fangyuan, et al.
Publicado: (2022)

Editorial: Mucosal Vaccination: Strategies to Induce and Evaluate Mucosal Immunity
por: Kozlowski, Pamela A., et al.
Publicado: (2022)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

Eyedrop Vaccination Induced Systemic and Mucosal Immunity against Influenza Virus in Ferrets
por: Yoon, Sangchul, et al.
Publicado: (2016)

A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model
por: Pliasas, Vasilis C., et al.
Publicado: (2022)

Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice
por: Silveira, Fernando, et al.
Publicado: (2023)

Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus
por: Bodas-Pinedo, Andrés, et al.
Publicado: (2023)

Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection
por: Kim, So-Hee, et al.
Publicado: (2013)

Varicella Zoster Virus infects mucosal associated Invariant T cells
por: Purohit, Shivam K., et al.
Publicado: (2023)

Editorial: New-generation vaccines and novel vaccinal strategies against infectious diseases of livestock, wild and companion animals
por: Pickering, Brad, et al.
Publicado: (2023)

U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice
por: Risso, Gabriela S., et al.
Publicado: (2017)

Intranasal Vaccination with an Engineered Influenza Virus Expressing the Receptor Binding Subdomain of Botulinum Neurotoxin Provides Protective Immunity Against Botulism and Influenza
por: Li, Junwei, et al.
Publicado: (2015)

A Combination of Deworming and Prime-Boost Vaccination Regimen Restores Efficacy of Vaccination Against Influenza in Helminth-Infected Mice
por: Stetter, Nadine, et al.
Publicado: (2021)

Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo
por: Koch, Rebecca M., et al.
Publicado: (2017)

Emerging Role of Mucosal Vaccine in Preventing Infection with Avian Influenza A Viruses
por: Wang, Tong, et al.
Publicado: (2020)

Partial Protection against Porcine Influenza A Virus by a Hemagglutinin-Expressing Virus Replicon Particle Vaccine in the Absence of Neutralizing Antibodies
por: Ricklin, Meret E., et al.
Publicado: (2016)

Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets
por: McKay, P F, et al.
Publicado: (2022)

Comprehensive Transcriptomic Analysis Identifies Novel Antiviral Factors Against Influenza A Virus Infection
por: Zhou, Ao, et al.
Publicado: (2021)

An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection
por: van der Ley, Peter A., et al.
Publicado: (2021)

Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice
por: Liu, Yonghong, et al.
Publicado: (2021)

Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus
por: Kingstad-Bakke, Brock, et al.
Publicado: (2021)

Systemic and Mucosal B and T Cell Responses Upon Mucosal Vaccination of Teleost Fish
por: Muñoz-Atienza, Estefanía, et al.
Publicado: (2021)

Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection
por: Tian, Maopeng, et al.
Publicado: (2018)

Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant
por: Christensen, Dennis, et al.
Publicado: (2018)

Correction: Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection
por: Kim, So-Hee, et al.
Publicado: (2013)

Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections
por: Trottein, François, et al.
Publicado: (2018)

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination
por: Bomsel, Morgane, et al.
Publicado: (2023)

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
por: del Fresno, Carlos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1g92tf5l0dsmq2878tsjggginc